US2021008171A1PendingUtilityA1
Multiparticulate granulate comprising insulin
Est. expiryJun 12, 2037(~10.9 yrs left)· nominal 20-yr term from priority
Inventors:Roman Safonov
A61K 38/28A61K 9/1652A23L 33/18A61K 9/10A23L 33/40A61K 9/141A61K 9/0095A23L 33/30
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is directed to multiparticulate granulate compositions comprising particles of insulin and particles of an infant nutritional excipient, wherein the multiparticulate granulate is substantially free of layers of insulin and excipient, methods of making thereof, and methods of use thereof.
Claims
exact text as granted — not AI-modified1 . A composition-of-matter comprising particles of insulin dispersed on particles of an infant nutritional excipient.
2 . (canceled)
3 . The composition-of-matter of claim 1 , wherein the infant nutritional excipient comprises maltodextrin.
4 . (canceled)
5 . (canceled)
6 . The composition-of-matter of claim 1 , having a particle size ranging from about 125 μm to about 1000 μm and an average particle size ranging from about 200 μm to about 600 μm, monomodal distribution. cm 7 - 11 . (canceled)
12 . The composition-of-matter of claim 1 , wherein a ratio of the particles of infant nutritional excipient to the particles of insulin ranges from about 2,500:1 to about 750,000:1.
13 . The composition-of-matter of claim 1 , wherein the amount of insulin in the particles of insulin ranges from about 0.0001 wt. % to about 0.04 wt. %.
14 . The composition-of-matter of claim 1 , having a moisture content of is no more than about 6.5 wt. %.
15 . The composition-of-matter of claim 1 , wherein the particles of insulin include no more than about 5 wt. % A-21 desamido human insulin.
16 . The composition-of-matter of claim 1 , wherein the particles of insulin include no more than about 15 wt. % total related proteins.
17 . (canceled)
18 . The composition-of-matter of claim 1 , having a bulk uniformity of about 90-20% with an RSD of not more than about 5%.
19 . The composition-of-matter of claim 1 , wherein at least 80% of the composition-of-matter dissolves within 5 minutes when dispersed in 2/3 by wt. 0.9% saline at 25° C.
20 . The composition-of-matter of claim 1 , wherein the insulin concentration is 0.04-8.
21 - 27 . (canceled)
28 . The composition-of-matter of claim 1 , having a flow index of 10-30 seconds per 1.00 g when passed through a 10 mm orifice.
29 - 49 . (canceled)Join the waitlist — get patent alerts
Track US2021008171A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.